Accessibility Menu
Rockwell Medical Stock Quote

Rockwell Medical (NASDAQ: RMTI)

$1.14
(-3.4%)
-0.04
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$1.14
Daily Change
(-3.4%) $0.04
Day's Range
$1.12 - $1.19
Previous Close
$1.14
Open
$1.18
Beta
1.34
Volume
927
Average Volume
1,406,490
Market Cap
39.3M
Market Cap / Employee
$1.14M
52wk Range
$0.78 - $5.15
Revenue
-
Gross Margin
0.18%
Dividend Yield
N/A
EPS
-$0.07
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Rockwell Medical Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
RMTI-67.05%-89.2%-35.93%-98%
S&P+14.5%+93.32%+14.09%+591%

Rockwell Medical Company Info

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$16.07M-37.8%
Gross Profit$2.50M-45.0%
Gross Margin15.57%-2.0%
Market Cap$28.98M-45.7%
Market Cap / Employee$0.12M0.0%
Employees2443.0%
Net Income-$1.49M-623.5%
EBITDA-$0.79M-173.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$12.48M5.2%
Accounts Receivable$8.08M-25.4%
Inventory4.2-29.3%

Liabilities

Q2 2025YOY Change
Long Term Debt$11.27M-3.5%
Short Term Debt$2.74M1.2%

Ratios

Q2 2025YOY Change
Return On Assets-4.41%6.2%
Return On Invested Capital-60.69%30.7%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$1.68M45.3%
Operating Free Cash Flow$1.84M27.9%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book5.242.261.180.92-63.43%
Price to Sales1.300.660.390.33-44.63%
Price to Tangible Book Value10.193.691.791.41-75.25%
Price to Free Cash Flow TTM48.8521.0217.8410.84-
Enterprise Value to EBITDA50.272565.41-41.51-31.40-156.73%
Free Cash Flow Yield2.0%4.8%5.6%9.2%-
Return on Equity-6.0%-2.9%-2.1%-8.6%-70.43%
Total Debt$14.18M$13.54M$12.87M$14.01M-2.57%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.